Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | TRLV | ASTH |
|---|---|---|
| Price | $10.65 | $36.81 |
| Change today | ▼ 0.65% | ▲ 2.59% |
| Market cap | $2.05B | $2.05B |
| Return, 3 months | +19.3% | -21.7% |
| Return, year to date | +22.6% | +48.4% |
| Return, 1 year | +20.3% | +27.5% |
| P/E (TTM) | -4.3 | 44.9 |
| P/B | 2.7 | 2.5 |
| P/E percentile vs own 5y | 43rd | – |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | +67.2% | +41.3% |
| Analyst buy share | 100% | 89% |
| RSI (14) | 41 | 51 |
| 30-day volatility | 60.8% | 45.7% |
| Max drawdown, 1 year | -54.4% | -46.4% |
| Trend read | Leaning bearish | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
